McDonald's Corp vs Revvity Inc — how do they compare? McDonald's Corp trades at $264.05 (market cap $190.16B), while Revvity Inc trades at $110.7 (market cap $11.87B). The key difference: McDonald's Corp is far larger — about 16× Revvity Inc's market cap, and McDonald's Corp pays the higher dividend (2.78%). Which is the better fit depends on your goals.
| MCD | RVTY | |
|---|---|---|
Market Cap | $190.16B | $11.87B |
Volume | 2,230,036 | — |
Sector | Consumer Cyclical | Technology |
52-Week High | $341.06 | $117.75 |
52-Week Low | $264.54 | $82.26 |
Enterprise Value | $243.87B | $14.36B |
Dividend Yield | 2.78% | 0.26% |
Signals from Pluang's Aura AI — not financial advice
McDonald's (MCD) trades at $267.71, down 2.1% on the day, with a bearish technical signal driven by moving averages. The company reported steady revenue growth to $26.89 billion in 2025 and a net income margin of 31.62%, though Q2 2026 earnings are pending. Recent news highlights a new 'McDonald's NEXT' strategy focusing on automation and menu improvements to boost competitiveness.
The stock presents a buying opportunity with a consensus price target of $329, implying 23% upside, supported by strong analyst sentiment (58% buy ratings). Risks include inflationary pressures on franchisee margins and high long-term debt of $38.42 billion. Earnings execution and strategy rollout will be key for near-term performance.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
McDonald's Corporation franchises and operates fast-food restaurants in the global restaurant industry. The Company's restaurants serves a variety of value-priced menu products in countries around the world.
Read more on MCD →Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →